UK dividends calendar - next 7 days Read More
LONDON BROKER RATINGS: JPMorgan lifts price targets for Dechra and GSK Read More
IN BRIEF: GSK's ViiV Healthcare gets US approval for Apretude Read More
TOP NEWS: GSK appoints former Tesco CEO as consumer spin-off's chair Read More
LONDON MARKET PRE-OPEN: Former Tesco chief to chair Glaxo consumer Read More
GlaxoSmithKline's Covid treatment Xevudy authorised by EU regulators Read More
TOP NEWS: GSK, Sanofi Covid jab booster shows strong immune response Read More
LONDON MARKET PRE-OPEN: UK inflation races; GSK in decent booster data Read More
TOP NEWS: Glaxo gets positive test results for plant-based Covid jab Read More
IN BRIEF: Glaxo says further tests show Covid-19 drug fights Omicron Read More
LONDON MARKET CLOSE: Stocks fall as Omicron variant fears mount Read More
LONDON MARKET OPEN: Mood switches again after Omicron detected in US Read More
TOP NEWS: GSK says Covid-19 treatment works against Omicron variant Read More
LONDON BRIEFING: GlaxoSmithKline's Covid treatment copes with Omicron Read More
LONDON MARKET PRE-OPEN: GSK-Vir's sotrovimab works against Omicron Read More
LONDON BROKER RATINGS: Hochschild Mining hit with three downgrades Read More
LONDON MARKET CLOSE: Stocks mixed on Europe Covid resurgence fears Read More
LONDON MARKET MIDDAY: FTSE left behind as CAC and DAX hit records Read More
GSK gets USD1 billion US deals; Nucala is approved for three diseases Read More
GlaxoSmithKline Comet trial in Covid vaccine meets primary endpoint Read More
